🇺🇸 FDA
Patent

US 11000481

Composite preparation of mosapride and rabeprazole

granted A61KA61K31/4439A61K31/5375

Quick answer

US patent 11000481 (Composite preparation of mosapride and rabeprazole) held by KOREA UNITED PHARM. INC. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KOREA UNITED PHARM. INC.
Grant date
Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4439, A61K31/5375, A61K47/38, A61K9/2054